Keywords: vernalis, co-promote, frova, america, uk, group, decided
Vernalis to co-promote Frova in N America
Article | 07 March 2005
UK group Vernalis has decided to establish a US commercial infrastructure through exercising its option with Endo Pharmaceuticals to co-promote ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
